Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
MD Anderson Cancer Center
Oct 9, 2023, 18:18 |
Blog
Vivek Subbiah: Mark your calendars if you are attending the NCI AACR EORTC 2023- The triple meeting in Boston, Oct 11-15.
Vivek Subbiah shared on LinkedIn: “Mark your calendars if you are attending the NCI AACR…
Oct 7, 2023, 18:05 |
Insight
Natalia Baran: Our work on combination of dasatinib and antiPD1 in Philadelphia(Ph+) BALL just published in JITC. So thankful to all coauthors, who contributed to this work.
Oct 7, 2023, 17:20 |
Blog
15 posts from ASTRO23 not to miss.
The 65th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2023) took place at…
Oct 5, 2023, 15:09 |
Blog
Priya Chudasama: It is my privilege to be a part of the Omics and Models working group.
Priya Chudasama, Group Leader at DKFZ German Cancer Research Center, recently shared on LinkedIn: "The…
Oct 4, 2023, 21:05 |
Blog
Naveen Pemmaraju: Honored to be invited to speak on Updates in BPDCN at Soho Italy in Rome, Italy this week!
Naveen Pemmaraju, made the following post on Twitter: "Honored to be invited to speak on Updates…
Oct 3, 2023, 18:09 |
Blog
Mohamed Derbala: Excited to share our latest editorial in JAMA Oncology.
Quoting Mohamed Derbala, Research Scientist at the MD Anderson Cancer Center, on X/Twitter: "Excited to…
Oct 3, 2023, 17:55 |
Insight
We asked Chatgpt to identify nuclei larger than 15 microns in diameter! Not bad, isn't it! - Journal of Clinical Pathology
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology, and Scientific Director of the Sheikh…
Oct 1, 2023, 16:07 |
Blog
Vivek Subbiah: Fantastic keynote lecture on “The FDA perspective on early phase pre-market dose optimization” by the amazing Dr. Paul Kluetz.
Vivek Subbiah shared on X/Twitter: “Fantastic keynote lecture on “The FDA perspective on early phase pre-market…
Sep 29, 2023, 18:30 |
Blog
Vivek Subbiah: Thanks to Ishwaria Subbiah for discussing this crucial topic with the US Social Security Administration.
Vivek Subbiah shared a post by Ishwaria Subbiah on LinkedIn, adding: ''Cancer is the 2nd…
Sep 28, 2023, 20:32 |
Blog
Vivek Subbiah: So much enthusiasm for delivering Precision Medicine every where.
Vivek Subbiah, made the following post on LinkedIn: "Delighted to visit Park City, Utah to deliver…
135
136
137
138
139
All:
1456
Posts:
1361 - 1370
Targeted Therapy vs Immunotherapy: Which Is Right for You, Key Differences & Similarities
ASTRO24: 20 Posts Not To Miss From Day 1
Fran Drescher and Uterine Cancer: How She Went Against, How She Survived, and More
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube